title: Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
authors.affiliation: Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City 73112.
authors.forename: D K
authors.initials: DK
authors.lastname: Cooper
authors.forename: A H
authors.initials: AH
authors.lastname: Good
authors.forename: Y
authors.initials: Y
authors.lastname: Ye
authors.forename: E
authors.initials: E
authors.lastname: Koren
authors.forename: R
authors.initials: R
authors.lastname: Oriol
authors.forename: R M
authors.initials: RM
authors.lastname: Ippolito
authors.forename: A J
authors.initials: AJ
authors.lastname: Malcolm
authors.forename: F A
authors.initials: FA
authors.lastname: Neethling
authors.forename: E
authors.initials: E
authors.lastname: Romano
authors.forename: N
authors.initials: N
authors.lastname: Zuhdi
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D001787:Blood Group Incompatibility; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D016030:Kidney Transplantation / Q000276:immunology; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology*; D010215:Papio; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D000017:ABO Blood-Group System; D000888:Antibodies, Anti-Idiotypic; D007166:Immunosuppressive Agents; D009844:Oligosaccharides